• Cisplatin (CDDP): Mechanism and Research Workflow

  2026-08-18

  Cisplatin, also called CDDP, is a platinum-based DNA crosslinking agent that disrupts replication and transcription and can activate apoptosis. This article connects its molecular mechanism with apoptosis assay design, xenograft research, renal-toxicity modeling, and chemotherapy resistance studies.

• Cepharanthine and EGFR Signaling in Nasopharyngeal Cancer

  2026-08-18

  This study combines network pharmacology, molecular docking, and experimental validation to investigate cepharanthine (CEP) in nasopharyngeal carcinoma. Its findings connect CEP activity with suppression of the EGFR/PI3K/AKT/mTOR axis and provide a mechanistic framework for evaluating CEP in future cancer research, while leaving questions about pharmacokinetics, target causality, and clinical translation unresolved.

• Gentamycin Sulfate for Reliable Cell Assays

  2026-08-17

  This scenario-based guide explains how Gentamycin Sulfate, SKU A2514, can support contamination control, bacterial infection models, and antibiotic-resistance experiments without obscuring mammalian cell-assay interpretation. It covers formulation, compatibility, workflow controls, resistance data, and practical supplier-selection criteria.

• Cy5-UTP for Fluorescent RNA Probe Synthesis

  2026-08-17

  Cy5-UTP, also called Cyanine 5-uridine triphosphate, is a fluorescent UTP analog for T7 in vitro transcription RNA labeling. Its 650/670 nm excitation and emission maxima support direct detection of labeled RNA for RNA probe synthesis, FISH, and dual-color expression arrays.

• TaSERL2–TaBZR2 Control of Wheat Heat Tolerance

  2026-08-16

  The reference study identifies a TaSERL2–TaBZR2 regulatory module that connects receptor-like kinase phosphorylation with wheat thermotolerance. TaBZR2 promotes heat-stress tolerance, whereas TaSERL2 suppresses it by reducing TaBZR2 stability and transcriptional activity; heat stress weakens this inhibition by lowering phosphorylation.

• SMYD2 Inhibition in Cisplatin-Induced Renal Fibrosis

  2026-08-15

  The reference study identifies SMYD2 as a pharmacologically tractable regulator of cisplatin-induced chronic kidney disease, linking its inhibition with reduced renal fibrosis, epithelial–mesenchymal transition, and inflammation. By evaluating AZ505 and LLY507 in an injury model and tubular epithelial cells, the work provides a mechanistic foundation for studying SMYD2–Smad3/STAT3 signaling in renal pathology.

• RITA (NSC 652287) Assay Workflow Guide

  2026-08-14

  RITA (NSC 652287) combines MDM2-p53 pathway interrogation with DNA cross-linking activity, making it useful for mechanism-aware viability and apoptosis workflows. This guide shows how to separate growth arrest from true cell killing, optimize dosing, and extend findings from renal carcinoma research into tumor xenograft model planning.

• H. pylori, HNF4A, and Gastric Cancer Epigenetics

  2026-08-14

  The reference study identifies promoter hypermethylation of HNF4A as a mechanistic link between Helicobacter pylori infection, loss of gastric epithelial polarity, and activation of TGFβ-associated EMT signaling. Its integrated clinical, single-cell, cellular, and in vivo evidence supports HNF4A silencing as a functional driver of gastric tumorigenesis and metastasis, while suggesting a testable framework for tumor suppressor gene reactivation studies.

• Cisplatin Workflows for Sensitivity and Apoptosis

  2026-08-13

  Build reproducible CDDP experiments around DNA damage, apoptosis, and resistance rather than relying on a single viability endpoint. APExBIO’s Cisplatin supports dose-response, combination, and mechanistic workflows spanning cancer research and translational tumor models.

• Nanoparticle Uptake by Corneal Cells: Size and Chemistry

  2026-08-13

  The reference study establishes a controlled PLGA nanoparticle platform for separating the effects of particle size and surface chemistry on uptake by human corneal epithelial cells. Its results identify energy-dependent endocytosis, particularly macropinocytosis and caveolae-mediated uptake, as the principal routes under the tested in vitro conditions and provide design guidance for topical ocular delivery.

• H. pylori–HNF4A Methylation Drives Gastric Cancer

  2026-08-12

  The reference study identifies a mechanistic link between Helicobacter pylori infection, HNF4A promoter hypermethylation, epithelial polarity loss, and TGFβ-associated EMT in gastric cancer. Its integrated clinical, single-cell, cellular, and animal evidence positions HNF4A silencing as a potentially actionable model for cancer epigenetics and solid tumor epigenetic studies.

• Mubritinib Reveals OXPHOS Dependency in AML

  2026-08-12

  Baccelli et al. used a chemical screen of sequenced primary AML specimens to identify Mubritinib (TAK 165) as a selective inhibitor of electron transport chain complex I rather than a clinically relevant HER2-dependent agent in this disease context. The study links Mubritinib sensitivity to OXPHOS hyperactivity and a genetically distinct subset of chemotherapy-resistant AML, providing a rationale for metabolism-informed therapeutic stratification.

• Phenylalanine Nanostructures Sensitize ICB

  2026-08-11

  The reference study shows that metal-ion-chelating l-phenylalanine nanostructures can activate dendritic cells by coupling ion-channel regulation to NLRP3 inflammasome and NF-κB signaling. Short-term starvation improves nanostructure uptake and strengthens tumour-specific cytotoxic T-cell responses, providing a mechanistic strategy for improving immune checkpoint blockade in breast and colorectal tumour models.

• RITA (NSC 652287) Assay Workflows

  2026-08-11

  RITA (NSC 652287) enables a focused way to probe MDM2-p53 signaling, DNA cross-link-associated stress, and selective tumor-cell responses. This workflow pairs dose–response testing with separate growth and cell-death measurements so renal carcinoma research does not confuse proliferation arrest with true killing.

• CGRP/SP–Piezo2 Signaling in Trigeminal Allodynia

  2026-08-10

  Liao et al. identify a Ca2+-dependent CGRP/SP–Piezo2 feedback loop linking trigeminal root compression, neuroinflammation, and mechanical allodynia. Their rat and cell-based experiments position the TG neuron–Merkel cell axis as a mechanistic bridge between ATP signaling, PKC/MAPK activation, and abnormal facial mechanosensitivity.

8618 records 4/575 page Previous Next 12345 下5页 Last page